Company Quick10K Filing
Kemet
10-K 2020-03-31 Filed 2020-05-28
10-Q 2019-12-31 Filed 2020-02-06
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-01
10-K 2019-03-31 Filed 2019-05-30
10-Q 2018-12-31 Filed 2019-02-01
10-Q 2018-09-30 Filed 2018-11-02
10-Q 2018-06-30 Filed 2018-08-01
10-K 2018-03-31 Filed 2018-05-25
10-Q 2017-12-31 Filed 2018-02-01
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-08-08
10-K 2017-03-31 Filed 2017-06-01
10-Q 2016-12-31 Filed 2017-02-02
10-Q 2016-09-30 Filed 2016-11-02
10-Q 2016-06-30 Filed 2016-08-03
10-K 2016-03-31 Filed 2016-05-25
10-Q 2015-12-31 Filed 2016-02-02
10-Q 2015-09-30 Filed 2015-11-03
10-Q 2015-06-30 Filed 2015-08-03
10-K 2015-03-31 Filed 2015-05-22
10-Q 2014-12-31 Filed 2015-02-03
10-Q 2014-09-30 Filed 2014-10-31
10-Q 2014-06-30 Filed 2014-08-01
10-K 2014-03-31 Filed 2014-05-30
10-Q 2013-12-31 Filed 2014-02-04
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-08-02
10-K 2013-03-31 Filed 2013-06-06
10-Q 2012-12-31 Filed 2013-02-08
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-03
10-K 2012-03-31 Filed 2012-05-18
10-Q 2011-12-31 Filed 2012-02-03
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-08-03
10-K 2011-03-31 Filed 2011-05-20
10-Q 2010-12-31 Filed 2011-02-08
10-Q 2010-09-30 Filed 2010-10-29
10-Q 2010-06-30 Filed 2010-08-05
10-K 2010-03-31 Filed 2010-05-25
10-Q 2009-12-31 Filed 2010-02-03
8-K 2020-06-17
8-K 2020-06-09
8-K 2020-05-14
8-K 2020-05-12
8-K 2020-04-29
8-K 2020-04-24
8-K 2020-03-11
8-K 2020-02-20
8-K 2020-02-06
8-K 2020-02-03
8-K 2019-11-11
8-K 2019-11-11
8-K 2019-11-08
8-K 2019-08-01
8-K 2019-07-31
8-K 2019-05-22
8-K 2019-05-16
8-K 2019-03-20
8-K 2019-02-13
8-K 2019-01-31
8-K 2019-01-14
8-K 2018-12-20
8-K 2018-12-19
8-K 2018-11-29
8-K 2018-11-26
8-K 2018-11-07
8-K 2018-11-07
8-K 2018-10-30
8-K 2018-10-30
8-K 2018-10-29
8-K 2018-09-11
8-K 2018-09-06
8-K 2018-09-04
8-K 2018-07-26
8-K 2018-07-25
8-K 2018-07-25
8-K 2018-05-30
8-K 2018-05-23
8-K 2018-05-17
8-K 2018-04-18
8-K 2018-03-22
8-K 2018-02-02
8-K 2018-02-01
8-K 2018-01-17

Kemet Financials

KEM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6611712815213412713621118816013896535856585852565631374365537587110226254284287245263237208220193
Accounts Receivable15715414816114511410210510699979710110394991019692919693899389888393138139140144161157148154155163
Inventory152184208206240225212212216225221206218209201188189189188172183184175169168165155148192200201204206213233241256268
PP&E3023082983103173102903163113163131,0763103113041,0982912752651,0541,0651,0621,0471,0571,0482212121,0313673723751,2723974084381,376518528
Assets7198098348849058828029761,2001,2341,2051,2191,2268808621,2558398178001,2981,3151,3151,3049919961,0041,0191,1051,1111,1471,1721,2181,1791,2101,2311,3181,3911,402
Accounts Payable69829091957471748782627490817275847362707770647167646270136138133140143138144153162137
Long-Term Debt272274272273268267231347361361383384383403402399404402405391396395395391386386386388335332328325320317306294312306
Liabilities4824366175745925826246576426247186206025847301,1851,1841,179440908922929463725731734755710697693679714751
Stockholders' Equity400365359626642623594569238238537218215216568131130124551888390643385416438463469513538639677651
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue244249265261290266219211241234216215237213207216213221201194222223211184214218211198274301306318328349350356345327
Cost of Revenue230229224214
Gross Profit88126122114
R&D66777778877-166677667666677779101011111111121212
SG&A2425272830312528273125302724222525262325302322262626272938424848495248544849
Tax1110232-42203211-313100132212-01323523-49172
Net Income-203527213263-4213272322113193537419340-15
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating453193952199-35-719-0-24916-1214-5281111033826193010304338-16494934
Cash Investing-7-2-6-15-17-12-48-05-52-50-6-2-6-48-77-50-3-4-40-4-5-11160-10-10-38-15-25-68-39
Cash Financing-10-0-3-0-6011416-827-13-09-2-135-132-214-1-0-70-0-13-557-4-4-4-4-1116